Literature DB >> 7196209

Effects of Mg-pemoline on the central catecholaminergic system.

V A Molina, O A Orsingher.   

Abstract

Acute or repeated treatment with Mg-Pemoline (Mg-Pg) did not modify the endogenous level of brain catecholamines (CA) of rats. However, a single dose (30 mg/kg) produced a significant decrease of brain CA turnover, measured either by the rate of conversion of 14C-tyrosine to CA or by the rate of disappearance of CA after alpha-MT. Mg-Pe (0.01-0.1 mM) did not modify the basal outflow nor the release of 3H-DA elicited by high K+ in slices of corpus striatum. At the same concentrations, Mg-Pe inhibited uptake of DA (competitively) or NA (uncompetitively) in synaptosomes from corpus striatum and hypothalamus, respectively. Turning-behavior in mice lesioned in corpus striatum with 6-OH-DA, indicated that this drug acts like amphetamine as an indirect DA agonist. These results suggest that central stimulant effects of Mg-Pe may be the consequence of CA-uptake inhibition and this effect may also account for the decrease of brain CA turnover.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196209

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  2 in total

Review 1.  Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation.

Authors:  Darragh P Devine
Journal:  Psychopharmacology (Berl)       Date:  2013-09-21       Impact factor: 4.530

2.  Pemoline and tetramisole 'positives' in english racehorses following levamisole administration.

Authors: 
Journal:  Ir Vet J       Date:  2010-08-01       Impact factor: 2.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.